Home › Funds › LAKEWOOD CAPITAL MANAGEMENT, LP › CRL

LAKEWOOD CAPITAL MANAGEMENT, LP position in CRL

CHARLES RIV LABS INTL INC · Health Care

LAKEWOOD CAPITAL MANAGEMENT, LP reported holding 56,750 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$16.7M, representing 0.90% of its reported portfolio and ranking #38 among its reported holdings. LAKEWOOD CAPITAL MANAGEMENT, LP has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)56.75K sh
Reported value held$16.74M
Portfolio Weight0.90%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How LAKEWOOD CAPITAL MANAGEMENT, LP's CRL position evolved

LAKEWOOD CAPITAL MANAGEMENT, LP first disclosed a stake in CRL in Q3 2023 at 87,740 shares (US$17.2M). The position peaked in Q1 2024 at 112,740 shares, worth US$30.5M. Across 13 filings, LAKEWOOD CAPITAL MANAGEMENT, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 56,750 shares valued at US$16.7M — a reduction of -77,250 shares quarter over quarter.. Notable position changes include a 51% trim in Q1 2026 (shares rose 31% over the following quarter), a 94% increase in Q2 2026 (shares rose 30% over the following quarter), a 58% trim in Q3 2026 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 87.74K $17.20M New
Q4 2023 117.74K $27.83M Add
Q1 2024 112.74K $30.55M Reduce
Q2 2024 111.74K $23.08M Reduce
Q3 2024 111.74K $22.01M Hold
Q4 2024 111.74K $20.63M Hold
Q1 2025 140.24K $21.11M Add
Q2 2025 140.24K $21.28M Hold
Q3 2025 140.24K $21.94M Hold
Q4 2025 140.24K $27.98M Hold
Q1 2026 69.00K $11.90M Reduce
Q2 2026 134.00K $30.39M Add
Q3 2026 56.75K $16.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 31 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has LAKEWOOD CAPITAL MANAGEMENT, LP held CRL?

LAKEWOOD CAPITAL MANAGEMENT, LP has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LAKEWOOD CAPITAL MANAGEMENT, LP's current position in CRL?

As of Q3 2026, LAKEWOOD CAPITAL MANAGEMENT, LP holds 56.75K shares of CRL (CHARLES RIV LABS INTL INC), valued at $16.74M, representing 0.90% of its reported portfolio and ranking #38.

Has LAKEWOOD CAPITAL MANAGEMENT, LP been buying or selling CRL?

In the latest 13F filing (Q3 2026), LAKEWOOD CAPITAL MANAGEMENT, LP reduced its position in CRL. The position peaked in Q1 2024 at 112.74K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.